Latest Breaking News On - Jorge plutzky - Page 1 : comparemela.com

Semaglutide shows promise in preventing heart disease

Studies began to demonstrate its ability to aid in weight loss and improve the overall health of patients, including those without diabetes.

Remote care approach improved therapy adheren

<p>A new study by investigators from Mass General Brigham &nbsp;demonstrated that a remote team focused on identifying, educating and prescribing therapy can improve guideline-directed-medical-therapy (GDMT) adherence in patients with type 2 diabetes and high cardiovascular and/or kidney risk. The research team observed that patients who received education simultaneously with medication management demonstrated a higher rate of medication uptake and initiated treatment earlier compared to patients who received education over two months prior to medication management.</p>

Remote Care Boosts Therapy Adherence in Type 2 Diabetics

TOS Past Presidents Discuss Selected Study Findings

TOS past presidents comment on SELECT study r

<p>New findings show that the medication known as Wegovy&reg; (semaglutide) can reduce existing heart disease in patients with obesity by 20%, according to a study co-authored by past presidents of The Obesity Society and published in <em>The</em> <em>New England Journal of Medicine</em>.</p>